LivaNova PLC - Ordinary Shares (LIVN): Price and Financial Metrics


LivaNova PLC - Ordinary Shares (LIVN)

Today's Latest Price: $52.54 USD

0.91 (-1.70%)

Updated Oct 26 4:00pm

Add LIVN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

LIVN Stock Summary

  • LivaNova PLC's stock had its IPO on October 19, 2015, making it an older stock than only 17.02% of US equities in our set.
  • With a year-over-year growth in debt of 165.54%, LivaNova PLC's debt growth rate surpasses 91.14% of about US stocks.
  • LivaNova PLC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -19.97%, greater than the shareholder yield of only 18.06% of stocks in our set.
  • Stocks that are quantitatively similar to LIVN, based on their financial statements, market capitalization, and price volatility, are LFUS, ROG, AMAG, OPK, and CPIX.
  • LIVN's SEC filings can be seen here. And to visit LivaNova PLC's official web site, go to www.livanova.com.

LIVN Stock Price Chart Interactive Chart >

Price chart for LIVN

LIVN Price/Volume Stats

Current price $52.54 52-week high $85.30
Prev. close $53.45 52-week low $33.40
Day low $51.88 Volume 365,500
Day high $52.92 Avg. volume 560,147
50-day MA $47.82 Dividend yield N/A
200-day MA $53.51 Market Cap 2.56B

LivaNova PLC - Ordinary Shares (LIVN) Company Bio


LivaNova PLC. offers cardiac surgery, cardiac rhythm management, and neuromodulation related products worldwide. The company was founded in 1987 and is based in London, England.


LIVN Latest News Stream


Event/Time News Detail
Loading, please wait...

LIVN Latest Social Stream


Loading social stream, please wait...

View Full LIVN Social Stream

Latest LIVN News From Around the Web

Below are the latest news stories about LivaNova PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.

Artificial Cardiopulmonary Machine Market 2020-28 plays a crucial role of the heart and lungs during surgical procedures| LivaNova, Terumo CV Group, Getinge, Medtronic, Tianjin Medical, Braile Biomedica

Artificial heart-lung machine, commonly known as Artificial Cardiopulmonary Machine or cardiopulmonary bypass pump, is used to take the role of the heart and lungs during any cardiovascular surgical procedure. The Artificial Cardiopulmonary Machine Market report is an extensive, proficient and

OpenPR | September 28, 2020

LivaNova to Host Conference Call for Third Quarter 2020 Results

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC will host a conference call to discuss its third quarter 2020 results on Thursday, October 29, 2020 at 12 p.m. London (8 a.m. EDT).

Business Wire | September 28, 2020

LivaNova to Present at the Baird 2020 Global Healthcare Conference

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC announced Damien McDonald, CEO, will present at the Baird 2020 Global Healthcare Conference on Thursday, Sept. 10 at 9:05 a.m. EDT.

Business Wire | September 1, 2020

LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2020

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova poster at ESC 2020 to share potential for autonomic regulation therapy to improve heart failure patients' long-term cardiovascular function.

Business Wire | August 12, 2020

Global Neurology Devices Market (2019 to 2025) - Featuring LivaNova, Magstim & Medtronic Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Neurology Devices Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The global neurology devices market is estimated to witness significant growth during the forecast period. Increasing demand for neurostimulation devices is one of the factors that are driving the market growth. Rising prevalence of neurological disorders, including Parkinson's and Alzheimer's disease has led the adoption of neurostimulation devices. In addition, rising

Business Wire | August 10, 2020

Read More 'LIVN' Stories Here

LIVN Price Returns

1-mo 24.36%
3-mo -5.52%
6-mo -1.85%
1-year -29.26%
3-year -28.51%
5-year -22.51%
YTD -30.35%
2019 -17.54%
2018 14.45%
2017 77.72%
2016 -24.25%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8931 seconds.